A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

DOI PDF Web Site Web Site 2 Citations

Journal

Citations (2)*help

See more

Keywords

Report a problem

Back to top